Chiropractic Offers Long Term Benefits for Fibromyalgia Sufferers

New Carrollton natural fibromyalgia treatmentIf you are afflicted by fibromyalgia, you are not alone, as Dr. Carl Heusler, DC sees many people with this particular condition in our New Carrollton chiropractic office. As a matter of fact, the Centers for Disease Control and Prevention (CDC) reports that roughly two percent of all adults in the US have fibromyalgia. Thankfully, chiropractic care is one treatment option that can provide positive results.

In a paper published in mid-2015, 215 women and men with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression symptoms and anxiety they felt. Then they were split into two groups with one group receiving a multi-modal treatment plan for three months and the second group receiving the same approach with the addition of chiropractic care (specifically, to the upper neck area) for the same length of time.

The individuals who received chiropractic adjustments combined with the multi-disciplinary treatment program reported greater results in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study patients who received multi-modal therapy without chiropractic care. Additionally, those positive results were lasting as the individuals reported continued improvement one full year later.

Fibromyalgia can substantially decrease your quality of life, both psychologically and physically. If you're struggling with fibromyalgia, we might be able to help.

You don't have to suffer! To find out what Dr. Carl Heusler, DC can do for your fibromyalgia, call our New Carrollton chiropractic office today.

Studies

  • Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
  • Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.
Tweet